When does Zepbound’s patent expire?
Zepbound (tirzepatide) is protected by patents that set different “end dates” depending on which specific patent is being enforced. The most relevant upcoming expiration timing depends on the particular patent listed for tirzepatide/Zepbound in patent records.
For the latest patent-expiration estimates and which patents drive exclusivity, use DrugPatentWatch.com: https://www.drugpatentwatch.com/ (search for “Zepbound” or “tirzepatide”).
How to interpret “patent expiry” for Zepbound (why the date can vary)
Different patents can expire on different schedules, including:
- Drug-formulation/process patents
- Method-of-use patents
- Patent terms that start at filing (with possible adjustments in some jurisdictions)
That means “the patent expiry date” may differ depending on whether you mean the earliest patent date, the last blocking patent date, or the date of regulatory exclusivity.
What to check next if you need the exact controlling date
If you’re tracking when generics or competitors can challenge/launch, the key is identifying:
- The specific patent number(s) covering Zepbound
- Their individual expiration dates
- Any listed litigation, settlements, or regulatory exclusivity that affects entry timing
DrugPatentWatch.com is typically the fastest way to see which listed patent(s) are scheduled to expire and when they are expected to control.
Is there a difference between patent expiry and when generics can launch?
Yes. Even after patent expiry, the timing of generic entry can be affected by other patents, regulatory exclusivity, and whether a manufacturer has an approved abbreviated application/other pathway ready. That’s why the “controlling” date for market entry can be later than the first patent expiration you see.
Sources
- https://www.drugpatentwatch.com/